Same Indication

Empagliflozin vs Paricalcitol

Empagliflozin vs Paricalcitol: Overview

This comparison examines the pharmacological differences between Empagliflozin and Paricalcitol.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Pharmacokinetics

Half-life: Empagliflozin β€” 12.4 hours.

Chemical Properties

Molecular Formula: Empagliflozin β€” C23H27ClO7.

Molecular Weight: Empagliflozin β€” 450.9100 g/mol.

Type: Empagliflozin β€” Small molecule; Paricalcitol β€” Small molecule.